This is a routine internal promotion with no immediate trading implications. Monitor for any strategic shifts under the new COO, but no near-term catalyst is expected.
Price Chart
Executive Summary
Eton Pharmaceuticals appointed Danka Radosavljevic, age 42, as Chief Operating Officer, effective July 31, 2026. She was previously Executive Vice President, Operations and has been with the company since 2017. This is an internal promotion of a long-tenured executive, which is a routine organizational change with no material financial impact.
Key Facts
- Danka Radosavljevic appointed COO effective July 31, 2026
- Previously held the role of Executive Vice President, Operations for more than five years
- Has been with Eton Pharmaceuticals since 2017
- Annual base salary of $520,800
- Annual discretionary incentive bonus target of 50% of base salary
Financial Impact
No material financial impact from this appointment
Risk Factors
- No material risks identified from this filing
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001437749-26-025506 |
| Document: 0001437749-26-025506-index-headers.html | 0001437749-26-025506 |
| Document: 0001437749-26-025506-index.html | 0001437749-26-025506 |
| Document: 0001437749-26-025506.txt | 0001437749-26-025506 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 14, 2026 13d ago | 8-K | $52.88 | awaiting T+60 | — | $49.46 (−6.48%) |
Oct 6, 2026 20d ago | 144 | $54.88 | awaiting T+60 | — | $49.46 (−9.89%) |
Sep 28, 2026 29d ago | 8-K | $59.18 | awaiting T+60 | — | $49.46 (−16.43%) |
Aug 31, 2026 8w ago | Insider Cluster | $60.43 | awaiting T+60 | — | $49.46 (−18.16%) |
Aug 28, 2026 8w ago | Insider Cluster | $60.44 | awaiting T+60 | — | $49.46 (−18.18%) |
Aug 24, 2026 9w ago | Insider Cluster | $63.05 | awaiting T+60 | — | $49.46 (+21.56%) |
Aug 19, 2026 9w ago | 144 | $61.48 | awaiting T+60 | — | $49.46 (+19.56%) |
Aug 5, 2026 11w ago | 8-K | $45.97 | awaiting T+60 | — | $49.46 (+7.58%) |
Aug 5, 2026 11w ago | Press Release | $45.97 | awaiting T+60 | — | $49.46 (+7.58%) |
Aug 4, 2026 12w ago | 8-K | $45.83 | awaiting T+60 | — | $49.46 (+7.91%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers